"Clinic Hours: Monday - Friday 8:00 AM - 5:00 PM (858) 657-8530"

During the past decade, UCSD Sulpizio Cardiovascular Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Sulpizio Cardiovascular Center" #1 sponsor was "University of California, San Diego" with 12 trials, followed by "Pfizer" with 4 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Cardiovascular Research Foundation, New York" with 1 trials sponsored and "HealthCore-NERI" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Sulpizio Cardiovascular Center" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Avania" with 1 trials as a collaborator and "Bard Ltd" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Sulpizio Cardiovascular Center" are "Cardiac Arrhythmia" (5 trials), "Heart Failure" (5 trials), "Atrial Fibrillation" (4 trials), "Cardiomyopathy" (3 trials) and "Transthyretin (TTR) Amyloid Cardiomyopathy" (2 trials). Many other conditions were trialed in "UCSD Sulpizio Cardiovascular Center" in a lesser frequency.

Most popular intervention types in "UCSD Sulpizio Cardiovascular Center" are "Device" (9 trials), "Drug" (6 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tafamidis" (2 trials), "Accelerometer Mode on Biotronik CRT-D" (1 trials), "Amigo™ Robotic Catheter Manipulation" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Sulpizio Cardiovascular Center" are 20 trials for "All" genders.

Currently, there are NaN active trials in "UCSD Sulpizio Cardiovascular Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in UCSD Sulpizio Cardiovascular Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Sulpizio Cardiovascular Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".